Abstract
ADAM15 plays an important role in tumour development by interacting with integrins. In this study, we investigated the target peptides of the ADAM15 disintegrin domain. First, we successfully produced the recombinant human ADAM15 disintegrin domain (RADD) that could inhibit melanoma cell adhesion by using Escherichia coli. Second, four specific binding peptides (peptides A, B, C, and D) were selected using a phage display 12-mer peptide library. The screening protocol involved 4 rounds of positive panning on RADD and 2 rounds of subtractive selection with streptavidin. By using the BLAST software and a relevant protein database, integrin α ν β 3 was found to be homologous to peptide A. Synthetic peptide A had a highly inhibitory effect on RADD-integrin α v β 3 binding. The results demonstrate the potential application of short peptides for disrupting high-affinity ADAM-integrin interactions.
Similar content being viewed by others
Abbreviations
- ADAM:
-
A Disintegrin And Metalloproteinase
- ASMC:
-
airway smooth muscle cell
- b-RADD:
-
biotinylated RADD
- BSA:
-
bovine serum albumin
- DMEM:
-
Dulbecco modified Eagle medium
- EGF:
-
epidermal growth factor
- ELISA:
-
enzyme-linked immunosorbent assay
- GST:
-
glutathione S-transferase
- HBSS:
-
Hanks balanced salt solution
- HMEC:
-
human microvascular endothelial cells
- HPLC:
-
high-performance liquid chromatography
- HRP:
-
horseradish peroxidase
- IL:
-
interleukin
- IPTG:
-
isopropyl-1-thio-β-D-galactopyranoside
- MALDI-TOF:
-
matrix-assisted laser desorption ionisation time of flight
- OPD:
-
o-phenylenediamine dihydrochloride
- PBS:
-
phosphate buffered saline
- RADD:
-
recombinant human ADAM15 disintegrin domain
- RGD:
-
Arg-Gly-Asp
- TBST:
-
Tris-buffered saline Tween-20
References
Arribas J, Bech-Serra J J and Santiago-Josefat B 2006 ADAMs, cell migration and cancer; Cancer Metastasis Rev. 25 57–68
Azzazy H M and Highsmith W E Jr 2002 Phage display technology: clinical applications and recent innovations; Clin. Biochem. 35 425–445
Beck V, Herold H, Benge A, Luber B, Hutzler P, Tschesche H, Kessler H, Schmitt M, Geppert HG, Reuning U 2005 ADAM15 decreases integrin alphavbeta3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion; Int. J. Biochem. Cell Biol. 37 590–603
Fleming T J, Sachdeva M, Delic M, Beltzer J, Wescott C R, Devlin M, Lander R C, Nixon A E, Roschke V, Hilbert D M, Sexton D J 2005 Discovery high affinity peptide binders BLyS phage display; J. Mol. Recognit. 18 94–102
Jeon O H, Kim D, Choi Y J, Kim S H, Choi W S and Kim D S 2007 Novel function of human ADAM15 disintegrin-like domain and its derivatives in platelet aggregation; Thromb. Res. 119 609–619
Karkkainen S, Hiipakka M, Wang J H, Kleino I, Vähä-Jaakkola M, Renkema G H, Liss M, Wagner R, Saksela K 2006 Identification of preferred protein interactions by phage-display of the human Src homology-3 proteome; EMBO Rep. 7 186–191
Kobayashi N and Yoshida T 2007 Binding sites on laminin receptors as components for antibiotics; Protein Pept. Lett. 14 33–36
Kratzschmar J, Lum L and Blobel C P 1996 Metargidin, a membrane-anchored metalloprotease-disintegrin protein with an RGD integrin binding sequence; J. Biol. Chem. 271 4593–4596
Lu D, Chung K F, Xia M, Lu X, Scully M and Kakkar V 2006 Integrin binding characteristics of the disintegrin-like domain of ADAM-15; Thromb. Haemost. 96 642–651
Lu D, Xie S, Sukkar M B, Lu X, Scully M F and Chung K F 2007 Inhibition of airway smooth muscle adhesion and migration by the disintegrin domain of ADAM-15; Am. J. Respir. Cell Mol. Biol. 37 494–500
Mochizuki S and Okada Y 2007 ADAMs in cancer cell proliferation and progression; Cancer Sci. 98 621–628
Nath D, Slocombe P M, Stephens P E, Warn A, Hutchinson G R, Yamada K M, Docherty A J and Murphy G 1999 Interaction of metargidin (ADAM-15) with alphavbeta3 and alpha5beta1 integrins on different haemopoietic cells; J. Cell Sci. 112 579–587
Steingroewer J, Bley T, Bergemann C and Boschke E 2007 Biomagnetic separation of Salmonella typhimurium with high affine and specific ligand peptides isolated by phage display technique; J. Magn. Magn. Mater. 311 295–299
Stone A L, Kroeger M and Sang Q X 1999 Structure-function analysis of the ADAM family of disintegrin-like and metalloproteinase-containing proteins; J. Protein Chem. 18 447–465
Trochon-Joseph V, Martel-Renoir D, Mir L M, Thomaïdis A, Opolon P, Connault E, Li H, Grenet C, Fauvel-Lafève F, Soria J, Legrand C, Soria C, Perricaudet M and Lu H 2004 Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin; Cancer Res. 64 2062–2069
Uvebrant K, da Graça Thrige D, Rosén A, Akesson M, Berg H, Walse B and Björk P 2007 Discovery of selective small-molecule CD80 inhibitors; J. Biomol. Screen 12 464–472
Wolfsberg T G, Primakoff P, Myles D G and White J M 1995 ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions; J. Cell Biol. 131 275–278
Xiong J P, Stehle T, Zhang R, Joachimiak A, Frech M, Goodman S L and Arnaout M A 2002 Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand; Science 296 151–155
Zhang X P, Kamata T, Yokoyama K, Puzon-McLaughlin W and Takada Y 1998 Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3; J. Biol. Chem. 273 7345–7350
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wu, J., Wu, MC., Zhang, LF. et al. Identification of binding peptides of the ADAM15 disintegrin domain using phage display. J Biosci 34, 213–220 (2009). https://doi.org/10.1007/s12038-009-0025-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12038-009-0025-3